Synth Logo

Get a high resolution logo for any domain or stock ticker — for free

Conduit Pharmaceuticals Inc. - Warrant (CDTTW) logo

PNG 2.39 KB
Download
https://logo.synthfinance.com/ticker/CDTTW
HTML
<img src="https://logo.synthfinance.com/ticker/CDTTW" />
About Conduit Pharmaceuticals Inc. - Warrant (CDTTW)

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Industry

Biotechnology

Sector

Healthcare